News

PharmiWeb4h
Electromedical Technologies, Inc. (OTC: EMED) Provides Mid-Year Update Highlighting Financial Restructuring, Regulatory Alignment, and Strategic Progress
Electromedical Technologies (OTC: EMED) outlines key financial restructuring milestones, upcoming product updates, and new ...
PharmiWeb3h
Colorado Eye Consultants Owner Dr. Robert Fish Honored as 5280 Magazine Top Doctor for 2025
LITTLETON, CO / ACCESS Newswire / August 6, 2025 / Colorado Eye Consultants announces that owner Dr. Robert Fish has been ...
PharmiWeb20m
Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth
Zomedica posts record year-over-year revenue for 18th straight quarter! ANN ARBOR, MI / ACCESS Newswire / August 6, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary ...
PharmiWeb6h
Global Electronic Drug Delivery Systems Market Set to Surge: Estimated at USD 11.6 Billion in 2024, Poised to Hit USD 21.6 B by 2033 at ~7.2% CAGR
The Electronic Drug Delivery Systems Market is experiencing robust, sustained expansion driven by rising chronic disease ...
PharmiWeb21m
NHI Announces Second Quarter 2025 Results
MURFREESBORO, TN / ACCESS Newswire / August 6, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and six months ended June 30, 2025.CEO Comments"We had ...
PharmiWeb21m
NHI Announces Increase for the Third Quarter 2025 Dividend
MURFREESBORO, TN / ACCESS Newswire / August 6, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its third quarter dividend of $0.92 per common share on October 31, ...
PharmiWeb21m
Protagonist Reports Second Quarter 2025 Financial Results and Provides Corporate Update
NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque psoriasis (PsO) submitted to U.S. FDA in JulyANTHEM Phase 2b trial data of ...
PharmiWeb26m
Viemed Healthcare Announces Second Quarter 2025 Financial Results
LAFAYETTE, LA / ACCESS Newswire / August 6, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment ...
PharmiWeb6h
Co-Founder of Velesco Pharmaceutical Appointed to Board of Directors at TSRL
TSRL, Inc., a preclinical CRO specializing in testing services and early-stage development strategies, announced today the ...
PharmiWeb1h
Deep Rx Inc. Appoints Dr. Stanley Marks, Chairman of UPMC Hillman Cancer Center, to Board of Directors to Advance AI-Driven Precision Oncology
PITTSBURGH, PA / ACCESS Newswire / August 6, 2025 / Deep Rx Inc., a predictive analytics company advancing AI-driven solutions for precision oncology, is pleased to announce the appointment of Stanley ...
PharmiWeb2h
Therabene Inc. Appoints Dr. Oscar L. Kashala as Chief Medical Officer and Executive Vice President of Global Clinical Development
Strategic Appointment to Accelerate Therabene's Oncology Drug Pipeline and Global Clinical Strategy NORWOOD, MA / ACCESS Newswire / August 6, 2025 / Therabene Inc., a biotechnology company pioneering ...
PharmiWeb10h
Europe Legal Cannabis Market Expected to Witness Significant Growth Amid Rising Legalization and Medical Adoption by 2035
Author:Shweta Raskar, Business Development Specialist, Prophecy Market InsightsIntroductionThe Europe Legal Cannabis Market ...